VERBESSERTE PEPTIDARZNEIMITTEL

Patent europeic · EP3444281 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3444281
Numer da la dumonda
EP18183208
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
20-11-2013
Publitgà
20-02-2019
Concedì
03-11-2021
La protecziun finescha il pli tard
19-11-2033
Proxima taxa annuala scadenta
30-11-2026
Classas IPC
C07K 19/00 (2006.01)
C07K 7/06 (2006.01)
A61K 38/08 (2019.01)
C07K 1/107 (2006.01)
A61K 38/00 (2006.01)
A61K 38/07 (2006.01)
A61K 38/26 (2006.01)
A61K 38/29 (2006.01)
C09D 101/28 (2006.01)
C07K 5/065 (2006.01)
Prioritad
US 201261728667 P 20.11.2012
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-12-2025

    Midada

    Published in Swissreg on 01.12.2025

  2. 01-12-2024

    Midada

    Published in Swissreg on 01.12.2024

  3. 01-12-2023

    Midada

    Published in Swissreg on 01.12.2023

  4. 06-12-2022

    Midada

    Published in Swissreg on 06.12.2022

  5. 14-09-2022

    Midada

    Published in Swissreg on 14.09.2022

  6. 03-11-2021

    Concedì

    Published in Swissreg on 03.11.2021

Partidas

Possessur

Eumederis Pharmaceuticals, Inc.

12707 High Bluff Drive, Suite 200, San Diego, CA 92130, US

Inventur

NESTOR, John, J

Sugar Land, TX 77479, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.